How much cash does AngioDynamics generate?

AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.

What is AngioDynamics's free cash flow?

After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.

Where does AngioDynamics's cash flow data come from?

Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

AngioDynamics ANGO Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q3 '26	TTM Q2 '26	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25
Net income	-$31.39M+24.2%	-$27.71M+87.7%	-$32.1M+86.8%	-$33.99M+81.6%	-$41.39M+78.5%
Depreciation and amortization	$23.19M-13.4%	$23.92M-14.5%	$25.04M-10.0%	$25.8M-6.9%	$26.78M-5.9%
Stock-based compensation	$11.69M+16.5%	$11.4M+11.3%	$11.04M+15.1%	$9.77M-7.2%	$10.03M-13.7%
Deferred income taxes	——	——	——	——	——
Impairment charges	$221K—	$221K—	-$47K—	$0—	——
Provision for credit losses	$359K-57.7%	$184K-84.2%	$537K-67.9%	$699K-47.3%	$849K-25.7%
Change in accounts receivable	$2.4M—	$1.46M—	——	——	——
Change in inventories	——	——	——	——	——
Change in accounts payable	——	——	——	——	——
Change in other assets	——	——	$1.6M-80.6%	-$3.09M-127%	$13.49M+97.1%
Other working capital changes	-$959K-1,432%	-$674K-242%	-$436K-541%	-$293K-573%	$72K+106%
Net cash from operating activities	——	——	——	——	——
Capital expenditures	$2.95M-30.8%	$3.73M+21.8%	$4.1M+45.5%	$4.46M+77.3%	$4.25M+41.4%
Net cash from investing activities	-$7.3M—	-$8.98M—	-$9.32M—	-$10.18M—	——
Repurchases of common stock	——	——	——	——	——
Proceeds from issuance of common stock	——	——	——	——	——
Payments for finance leases	$368K+534%	$331K—	$239K—	$148K—	$58K—
Net cash from financing activities	——	——	$397K+107%	-$255K+99.6%	$515K+101%
Effect of exchange rate changes on cash	——	——	$473K—	$398K—	——
Net increase (decrease) in cash	——	——	——	——	-$31.3M-165%
Interest paid	——	——	——	$185K—	$138.75K-78.5%
Income taxes paid	——	——	——	$800K+75.8%	$713.75K+67.3%
Change in Fair Value of Contingent Consideration	——	——	——	$272K-37.0%	$312K-65.5%
Change in fair value of contingent consideration	——	——	——	——	——
Deferred Income Tax Related To Operating Activity	——	——	——	-$988K+87.6%	-$2.73M+58.3%
Gain on sale of business and assets	——	——	——	$0-100%	$13.62M-66.7%
Impairment of assets held for sale	——	——	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	$1.6M-80.6%	-$3.09M-127%	$13.49M+97.1%
Non-cash Interest Expense	——	——	——	——	——
Non-cash lease expense	——	——	——	——	——
Non-cash lease expense	——	——	——	$1.96M+1.4%	$1.95M-5.7%
Other Noncash Income (Expense)	-$959K-1,432%	-$674K-242%	-$436K-541%	-$293K-573%	$72K+106%
Accounts Receivable, Credit Loss Expense (Reversal)	$359K-57.7%	$184K-84.2%	$537K-67.9%	$699K-47.3%	$849K-25.7%
Transaction costs for disposition	——	——	——	$0+100%	-$1.27M+66.7%
Increase In Placement And Evaluation Units	——	——	——	$5.71M+13.9%	$5.54M+8.4%
Payments To Acquire Intangible Assets Net Of Cash Acquired	——	——	——	$0-100%	$812.5K-68.4%
Finance Lease, Principal Payments	$368K+534%	$331K—	$239K—	$148K—	$58K—
Proceeds from issuance of common stock relating to employee stock plans	——	——	——	——	——
Proceeds from exercise of stock options and employee stock purchase plan	——	——	——	$933K+24.1%	$887.75K+3.6%
Interest Paid	——	——	——	$185K—	$138.75K-78.5%
Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1	-$71K+67.6%	-$30K-106%	-$111K-164%	-$49K+37.2%	-$219K—
Payments To Acquire Equipment On Lease	——	——	——	——	——
Proceeds From Issuance Of Other Long Term Debt	——	——	——	$0—	$0-100%
Proceeds from secured term loan	——	——	——	$6.31M—	$4.73M—
Income Taxes Paid, Net	——	——	——	$800K+75.8%	$713.75K+67.3%
Free cash flow	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about AngioDynamics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does AngioDynamics generate?: AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.
What is AngioDynamics's free cash flow?: After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.
Where does AngioDynamics's cash flow data come from?: Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.